Halogenated Oxabicyclo[3.2.1]octadiene with Dibromoenone-Based Building Blocks
FULL PAPER
tions with phenylboronic acid to afford 4a (39.8 mg, 80%) as a
colorless solid. 1H NMR (300 MHz, CDCl3): δ = 7.45 (s, 5 H), 6.96
(d, J = 2.0 Hz, 1 H), 3.91 (s, 3 H), 3.90 (s, 6 H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 184.9, 153.5, 145.6, 139.9, 132.7, 131.0,
(dd, J = 5.7, 1.9 Hz, 1 H), 6.62 (dd, J = 5.7, 2.4 Hz, 1 H), 5.46 (d, 128.6, 120.4, 116.4, 112.6, 109.6, 87.2, 84.1, 61.2, 56.4 ppm. IR
J = 1.9 Hz, 1 H), 5.20 (d, J = 2.4 Hz, 1 H) ppm. 13C NMR (thin film, cm–1): ν = 2940, 2184, 1696, 1575, 1501, 1238, 1130.
˜
(75 MHz, CDCl3): δ = 186.3, 161.1, 140.4, 134.7, 131.1, 130.3, HRMS: m/z 390.0095 (calcd. C18H15BrO5, 390.0103).
128.9, 127.9, 114.8, 86.9, 85.2 ppm. IR (thin film, cm–1): ν = 2979,
1699, 1585, 1186, 1072. HRMS: m/z 275.9762 (calcd. C8H7BrO2,
275.9786).
˜
(1S,5R)-3-Bromo-4-vinyl-8-oxabicyclo[3.2.1]octa-3,6-dien-2-one (4f):
To a 10 mL round-bottomed flask was added either 2 (100 mg,
0.36 mmol) or 3a (100 mg. 0.31 mmol). DMF (2 mL) was added,
(1S,5R)-3-Bromo-4-(4-methoxyphenyl)-8-oxabicyclo[3.2.1]octa-3,6-
dien-2-one (4b): Compound 2 (100 mg) was subjected to the coup-
ling conditions with (4-methoxyphenyl)boronic acid to afford 4b
(80 mg, 73 %) as a colorless solid; m.p. 122–123 °C. 1H NMR
(300 MHz, CDCl3): δ = 7.50 (d, J = 8.8 Hz, 2 H), 6.98 (d, J =
8.8 Hz, 2 H), 6.92 (dd, J = 5.7, 1.7 Hz, 1 H), 6.60 (dd, J = 5.7,
2.4 Hz, 1 H), 5.49 (d, J = 1.7 Hz, 1 H), 5.18 (d, J = 2.4 Hz, 1 H),
3.86 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 186.4, 161.3,
160.5, 140.3, 131.1, 130.0, 126.6, 114.3, 113.7, 86.9, 85.1, 55.6 ppm.
followed by Pd(PhCN)2Cl2 (14 mg, 0.036 mmol for 2; 12 mg,
0.031 mmol for 3a) and triphenylarsane (22 mg, 0.072 mmol for 2;
14 mg, 0.061 mmol for 3a). The reaction mixture was stirred at
25 °C until all material was dissolved. Vinyltributyltin (0.115 mL,
0.39 mmol for 2; 0.098 mL, 0.34 mmol for 3a) was added and the
solution stirred at 25 °C for 1 hour. The solvent was removed under
reduced pressure and the residue was purified by column
chromatography (SiO2, 10 g) using pentane (100 mL), followed by
10% ethyl acetate in hexanes as eluent to afford 4f as a yellow solid
(34 mg, 42% for 2; 21 mg, 30% for 3a): Rf = 0.44 (hexane/EtOAc,
IR (thin film, cm–1): ν = 2974, 2839, 1694, 1604, 1302, 1253, 1179,
˜
1
1072. HRMS: m/z 305.9854 (calcd. C14H11BrO3, 305.9891).
2:1). M.p. 63–65 °C. H NMR (500 MHz, CDCl3): δ = 6.92–6.85
(m, 2 H), 6.53 (dd, J = 5.9, 2.2 Hz, 1 H), 5.79 (d, J = 17.6 Hz, 1
H), 5.73 (d, J = 11.2 Hz, 1 H), 5.59 (d, J = 2.0 Hz, 1 H), 5.17 (dd,
J = 2.2, 0.7 Hz, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ =
186.6, 156.1, 139.5, 133.3, 131.4, 124.6, 117.5, 87.2, 80.3 ppm. IR
(1S,5R)-3-Bromo-4-(naphthalen-1-yl)-8-oxabicyclo[3.2.1]octa-3,6-
dien-2-one (4c): Compound 2 (100 mg) was subjected to the coup-
ling conditions with 1-napthylboronic acid to afford 4c (92 mg,
1
78%) as a colorless solid. H NMR (300 MHz, CDCl3): δ = 8.00–
(thin film, cm–1): ν = 3054, 2986, 1697, 1545, 1421, 1265. HRMS:
˜
7.86 (m, 5 H), 7.62–7.50(m, 4 H), 7.00 (dd, J = 5.7, 1.9 Hz, 1 H),
6.65 (dd, J = 5.7, 2.4 Hz, 1 H), 5.58 (d, J = 1.9 Hz, 1 H), 5.24 (d,
J = 2.4 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 186.3,
140.5, 133.6, 133.0, 132.0, 131.2, 130.9, 128.8, 128.7, 128.1, 128.1,
m/z 225.9630 (calcd. C9H7BrO2, 225.9629).
(1S,5R)-3,4-Bis(2-phenylethynyl)-8-oxabicyclo[3.2.1]octa-3,6-dien-2-
one (5): To a 10 mL round-bottomed flask was added 4d (205 mg,
0.68 mmol). Acetonitrile (3 mL) was added and the reaction mix-
ture stirred at 25 °C until all material was dissolved. Triethylamine
(3 mL) was added followed by copper(i) iodide (9.1 mg,
0.048 mmol) and Pd(dppf)2Cl2 (39 mg, 0.048 mmol). Phenylacety-
lene (0.083 mL, 0.75 mmol) was then added and the solution stirred
under argon for 1 hour. The solvent was removed under reduced
pressure and the residue was purified by column chromatography
(SiO2, 10 g) using 20% ethyl acetate in hexanes as the eluent to
afford 5 as a yellow oil (132 mg, 60%): Rf = 0.44 (hexane/EtOAc,
127.9, 127.2, 124.8, 87.0, 85.3 ppm. IR (thin film, cm–1): ν = 3057.
˜
2979, 1699, 1575, 1195, 1072; Analysis calcd. for C17H13BrO3: C,
62.41, H, 3.39. Found: C, 62.41, H, 3.25.
General Procedure of the Sonogashira Reaction: To a 10 mL round-
bottomed flask was added either 2 (100 mg, 0.36 mmol) or 3a
(100 mg, 0.31 mmol). Acetonitrile (2 mL) was added and the reac-
tion mixture stirred at 25 °C until all material was dissolved. Trieth-
ylamine (2 mL) was added followed by copper(i) iodide
(0.07 equiv.) and Pd(PhCN)2Cl2 (0.07 equiv.). The acetylene
(1.1 equiv.) was then added and the solution stirred under argon
for 10 minutes. The solvent was removed under reduced pressure
and the residue was purified by column chromatography.
1
4:1). H NMR (500 MHz, CDCl3): δ = 7.57–7.55 (m, 4 H), 7.45–
7.39 (m, 3 H), 7.36–7.35 (m, 3 H), 6.98 (dd, J = 5.6, 2.0 Hz, 1 H),
6.57 (dd, J = 5.8, 2.2 Hz, 1 H), 5.34 (d, J = 2.0 Hz, 1 H), 5.08 (d,
J = 2.2 Hz, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 188.16,
146.0, 139.6, 132.3, 132.1, 130.8, 130.4, 129.2, 128.9, 128.6, 122.8,
122.0, 120.5, 112.2, 99.3, 87.1, 85.4, 83.5, 82.9 ppm. IR (thin film,
(1S,5R)-3-Bromo-4-(2-phenylethynyl)-8-oxabicyclo[3.2.1]octa-3,6-
dien-2-one (4d): Compound 2 or 3a (100 mg) was subjected to the
coupling conditions using phenylacetylene. The residue was puri-
fied by column chromatography (SiO2, 10 g) using 15% ethyl ace-
tate in hexanes as eluent to afford 4d as a yellow oil which solidified
upon standing (85 mg, 79% for 2; 69 mg, 75% for 3a): Rf = 0.48
(hexane/EtOAc, 2:1). M.p. 86–88 °C. 1H NMR (500 MHz, CDCl3):
δ = 7.59–7.57 (m, 2 H), 7.48–7.44 (m, 1 H), 7.43–7.39 (m, 2 H),
7.01 (ddd, J = 5.6, 2.0, 0.7 Hz, 1 H), 6.58 (dd, J = 5.6, 2.2 Hz, 1
H), 5.35 (d, J = 2.0 Hz, 1 H), 5.20 (dd, J = 2.2, 0.7 Hz, 1 H) ppm.
13C NMR (125 MHz, CDCl3): δ = 184.9, 145.7, 140.0, 132.4, 131.0,
130.6, 128.9, 121.6, 120.8, 112.2, 87.2, 84.8, 84.1 ppm. IR (thin
cm–1): ν = 3063, 2980, 2179, 1704, 1543, 1491, 1443, 1364, 1209,
˜
1063. HRMS: m/z 322.1000 (calcd. C23H14O2, 322.0994).
(1S,2R,5R)-3-Bromo-4-(2-phenylethynyl)-8-oxabicyclo[3.2.1]octa-
3,6-dien-2-ol (6): To a 25 mL round-bottomed flask was added 4d
(200 mg, 0.66 mmol). Methanol (13 mL, 0.05 m) was added and the
reaction mixture was stirred at 25 °C until all material was dis-
solved. Cerium chloride (247 mg, 0.66 mmol) was added and
stirred to dissolve. The solution was cooled to –10 °C and sodium
borohydride (28 mg, 0.73 mmol) was added. The solution was
stirred at –10 °C for 1 hour and quenched with water (2.0 mL). The
solution was warmed to room temperature and the solvent re-
film, cm–1): ν = 3054, 2985, 2189, 1698, 1557, 1265, 1194. HRMS:
˜
m/z 299.9788 (calcd. C15H9BrO2, 299.9786).
(1S,5R)-3-Bromo-4-[2-(3,4,5-trimethoxyphenyl)ethynyl]-8-oxabicyclo- moved. The residue was taken up in ethyl acetate (10 mL) and
[3.2.1]octa-3,6-dien-2-one (4e): Compound 2 or 3a (100 mg) was
subjected to the coupling conditions using (3,4,5-trimethoxy-
phenyl)acetylene. The residue was purified by column chromatog-
raphy (SiO2, 10 g) using 20% ethyl acetate in hexanes as the eluent
to afford 4e as a yellow solid (123 mg, 88% for 2; 104 mg, 87% for
3a): Rf = 0.30 (hexane/EtOAc, 2:1). M.p. 145–147 °C. 1H NMR
washed with water (5 mL). The aqueous layer was extracted with
ethyl acetate (3×10 mL). The combined organics were washed with
brine, dried with sodium sulfate and concentrated. The residue was
purified by column chromatography (SiO2, 20 g) using 20% ethyl
acetate in hexanes as eluent to afford 6 as a colorless oil (170 mg,
85 %): Rf = 0.30 (hexane/EtOAc, 2:1). 1H NMR (500 MHz,
(500 MHz, CDCl3): δ = 7.01 (dd, J = 5.6, 1.5 Hz, 1 H), 6.79 (s, 2 CDCl3): δ = 7.52–7.50 (m, 2 H), 7.39–7.34 (m, 3 H), 6.90 (dd, 6.1,
H), 6.59 (dd, J = 5.6, 2.2 Hz, 1 H), 5.35 (d, J = 2.0 Hz, 1 H), 5.20 1.7 Hz, 1 H), 6.24 (dd, J = 6.1, 2.0 Hz, 1 H), 5.26 (dd, J = 6.1,
Eur. J. Org. Chem. 2005, 4296–4303
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4301